Ayurcann Holdings Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Igal Sudman

Chief Executive Officer (CEO)

CA$986.4k

Compensación total

Porcentaje del salario del CEO	23.4%
Permanencia del CEO	3.7yrs
Participación del CEO	23.1%
Permanencia media de la dirección	sin datos
Promedio de permanencia en la Junta Directiva	3.5yrs

Actualizaciones recientes de la dirección

Recent updates

Even With A 88% Surge, Cautious Investors Are Not Rewarding Ayurcann Holdings Corp.'s (CSE:AYUR) Performance Completely

Jun 28

Not Many Are Piling Into Ayurcann Holdings Corp. (CSE:AYUR) Stock Yet As It Plummets 33%

May 11

Market Cool On Ayurcann Holdings Corp.'s (CSE:AYUR) Revenues Pushing Shares 29% Lower

Mar 22

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Igal Sudman en comparación con los beneficios de Ayurcann Holdings?
Fecha	Compensación total	Salario	Ingresos de la empresa
Jun 30 2024	n/a	n/a	-CA$4m
Mar 31 2024	n/a	n/a	-CA$4m
Dec 31 2023	n/a	n/a	-CA$5m
Sep 30 2023	n/a	n/a	-CA$5m
Jun 30 2023	CA$986k	CA$230k	-CA$5m
Mar 31 2023	n/a	n/a	-CA$5m
Dec 31 2022	n/a	n/a	-CA$4m
Sep 30 2022	n/a	n/a	-CA$4m
Jun 30 2022	CA$188k	CA$188k	-CA$3m
Mar 31 2022	n/a	n/a	CA$401k
Dec 31 2021	n/a	n/a	CA$61k
Sep 30 2021	n/a	n/a	CA$61k
Jun 30 2021	CA$120k	CA$120k	-CA$278k

Compensación vs. Mercado: La compensación total de Igal($USD705.49K) está por encima de la media de empresas de tamaño similar en el mercado Canadian ($USD167.57K).

Compensación vs. Ingresos: La compensación de Igal ha aumentado mientras la empresa no es rentable.

CEO

Igal Sudman

3.7yrs

Permanencia

CA$986,370

Compensación

Mr. Igal Sudman serves as Chairman, Corporate Secretary & CEO of Ayurcann Holdings Corp. He is a Co-Founder of Ayurcann Holdings Corp. Mr. Sudman serves as Director of Ayurcann Holdings Corp. since March 2...

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Igal Sudman	Co-Founder	3.7yrs	CA$986.37k	23.13% CA$ 1.4m
Buzaker Roman	Co-Founder	3.7yrs	CA$984.29k	22.98% CA$ 1.3m
David Hackett	Independent Director	3.7yrs	CA$68.00k	0.66% CA$ 38.8k
Iris Bincovich	Member of Advisory Board	3.5yrs	sin datos	sin datos
Alison Gordon	Independent Director	3.7yrs	CA$60.00k	0.60% CA$ 34.8k
Michael Ash	Member of Advisory Board	3.5yrs	sin datos	sin datos
Trina Fraser	Member of Advisory Board	3.5yrs	sin datos	sin datos
Maor Shayit	Independent Director	3.7yrs	CA$60.00k	0.60% CA$ 34.8k
Barry Katzman	Member of Advisory Board	3.5yrs	sin datos	sin datos
Casey Hiltemann	Member of Advisory Board	3.5yrs	sin datos	sin datos
Benjamin Feferman	Member of Advisory Board	3.5yrs	sin datos	sin datos

3.5yrs

Permanencia media

Junta con experiencia: La junta directiva de AYUR se considera experimentada (3.5 años de antigüedad promedio).

Ayurcann Holdings Dirección

Dirección controles de criterios 1/4

Información clave

Actualizaciones recientes de la dirección

Ayurcann Holdings Corp., Annual General Meeting, Dec 20, 2023

High number of new and inexperienced directors

Ayurcann Holdings Corp., Annual General Meeting, Dec 21, 2022

High number of new and inexperienced directors

Recent updates

Arogo Capital Acquisition Corp. (NasdaqGM:AOGO) cancelled the acquisition of Ayurcann Holdings Corp. (CNSX:AYUR).

Full year 2024 earnings released: CA$0.022 loss per share (vs CA$0.035 loss in FY 2023)

Arogo Capital Acquisition Corp. (NasdaqGM:AOGO) entered into a definitive business combination agreement to acquire Ayurcann Holdings Corp. (CNSX:AYUR).

Even With A 88% Surge, Cautious Investors Are Not Rewarding Ayurcann Holdings Corp.'s (CSE:AYUR) Performance Completely

Third quarter 2024 earnings released: CA$0.002 loss per share (vs CA$0.007 loss in 3Q 2023)

Not Many Are Piling Into Ayurcann Holdings Corp. (CSE:AYUR) Stock Yet As It Plummets 33%

Market Cool On Ayurcann Holdings Corp.'s (CSE:AYUR) Revenues Pushing Shares 29% Lower

Second quarter 2024 earnings released: CA$0.005 loss per share (vs CA$0.001 loss in 2Q 2023)

First quarter 2024 earnings released: CA$0.001 loss per share (vs CA$0.007 loss in 1Q 2023)

Ayurcann Holdings Corp., Annual General Meeting, Dec 20, 2023

Full year 2023 earnings released: CA$0.035 loss per share (vs CA$0.026 loss in FY 2022)

Ayurcann Holdings Corp. Provides Corporate Update

Third quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.005 loss in 3Q 2022)

Second quarter 2023 earnings released: CA$0.001 loss per share (vs CA$0.002 loss in 2Q 2022)

First quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.001 profit in 1Q 2022)

High number of new and inexperienced directors

Ayurcann Holdings Corp., Annual General Meeting, Dec 21, 2022

Full year 2022 earnings released: CA$0.026 loss per share (vs CA$0.003 loss in FY 2021)

Ayurcann Holdings Corp. Expands Product Offerings Across Canada

Ayurcann Holdings Corp. (CNSX:AYUR) completed the acquisition of Joints and Hustle & Shake Inc. from Tetra Oils Inc. for CAD 3.6 million.

Third quarter 2022 earnings released: CA$0.005 loss per share (vs CA$0.011 loss in 3Q 2021)

High number of new and inexperienced directors

Ayurcann Holdings Corp. Receives Flower Sales Licence from Health Canada

Ayurcann Holdings Corp. (CNSX:AYUR) signed a letter of intent to acquire 100% interest in Joints and Hustle & Shake Inc. from Tetra Oils Inc.

Consensus forecasts updated

Second quarter 2022 earnings: EPS in line with expectations, revenues disappoint

First quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Full year 2021 earnings released: CA$0.003 loss per share (vs CA$0.008 loss in FY 2020)

Ayurcann Holdings Corp. announced that it has received CAD 0.602832 million in funding

Ayurcann Holdings Corp. announced that it expects to receive CAD 0.5 million in funding

Análisis de compensación del CEO

CEO

Permanencia

Compensación

Miembros de la Junta

Permanencia media